1. Home
  2. DTM vs BIO Comparison

DTM vs BIO Comparison

Compare DTM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTM
  • BIO
  • Stock Information
  • Founded
  • DTM 2021
  • BIO 1952
  • Country
  • DTM United States
  • BIO United States
  • Employees
  • DTM N/A
  • BIO N/A
  • Industry
  • DTM Oil & Gas Production
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DTM Utilities
  • BIO Industrials
  • Exchange
  • DTM Nasdaq
  • BIO Nasdaq
  • Market Cap
  • DTM 10.3B
  • BIO 9.2B
  • IPO Year
  • DTM N/A
  • BIO N/A
  • Fundamental
  • Price
  • DTM $98.48
  • BIO $279.94
  • Analyst Decision
  • DTM Hold
  • BIO Strong Buy
  • Analyst Count
  • DTM 11
  • BIO 4
  • Target Price
  • DTM $100.60
  • BIO $414.00
  • AVG Volume (30 Days)
  • DTM 940.3K
  • BIO 273.5K
  • Earning Date
  • DTM 02-26-2025
  • BIO 02-13-2025
  • Dividend Yield
  • DTM 2.98%
  • BIO N/A
  • EPS Growth
  • DTM 15.08
  • BIO N/A
  • EPS
  • DTM 4.11
  • BIO N/A
  • Revenue
  • DTM $976,000,000.00
  • BIO $2,566,500,000.00
  • Revenue This Year
  • DTM $7.79
  • BIO $4.19
  • Revenue Next Year
  • DTM $21.86
  • BIO $4.75
  • P/E Ratio
  • DTM $23.98
  • BIO N/A
  • Revenue Growth
  • DTM 5.97
  • BIO N/A
  • 52 Week Low
  • DTM $56.16
  • BIO $262.12
  • 52 Week High
  • DTM $114.50
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • DTM 41.65
  • BIO 26.04
  • Support Level
  • DTM $97.02
  • BIO $273.67
  • Resistance Level
  • DTM $103.08
  • BIO $289.96
  • Average True Range (ATR)
  • DTM 2.68
  • BIO 11.05
  • MACD
  • DTM -0.26
  • BIO -6.71
  • Stochastic Oscillator
  • DTM 20.35
  • BIO 7.40

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: